GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer
EGFR positive lung cancer patients who had seen cancer progression ...
EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.
-
HD
What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer?
"HSP 90 inhibitors are a really cool class of drugs..." ...
"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.
-
HD
What Is Non-Clear Cell Kidney Cancer?
Among kidney cancer patients, the sub-type "non-clear cell" is the ...
Among kidney cancer patients, the sub-type "non-clear cell" is the least common. As a result, not much research has been conducted on it.
-
HD
Does Gilotrif Help EGFR Positive Lung Cancer Patients?
An analysis of two large studies of EGFR lung cancer ...
An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer.
-
HD
The Promise of Immunotherapy in Lung Cancer
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential ...
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.
-
HD
Is Progression-Free Survival Meaningful?
Progression-free survival is something that doctors measure to determine how ...
Progression-free survival is something that doctors measure to determine how well a patient responds to a particular treatment. But does it translate to increased overall survival?
-
HD
DDR2 Mutations in Squamous Cell Lung Cancer
A genetic mutation and a leukemia drug may provide new ...
A genetic mutation and a leukemia drug may provide new hope for patients with squamous cell lung cancer patients.
-
HD
Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?
Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results ...
Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGFR positive lung cancer patients increase progression-free survival. June 2014.
-
HD
What is FGFR, and Could It Be a Valuable Target for Patients with Lung Cancer?
Dr. Joel Neal of Stanford University Medical Center talks about ...
Dr. Joel Neal of Stanford University Medical Center talks about FGFR - fibroblast growth factor receptor - and how it can impact non-small cell lung cancer growth.
-
HD
How Do We Make EGFR Inhibitors Work Better for Patients
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes what research ...
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes what research indicates may be more successful treatments for EGFR lung cancer patients.
